Karyopharm Therapeutics Inc. (KPTI) stock
KPTINasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as KPTIQ
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 1/30
$0.04−0.01 (-20.00%)
Close on Nov 9, 2026Market cap $1.16KP/E –Yield –
Karyopharm Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Karyopharm Therapeutics's enterprise value was -$64.19M on Nov 9, 2026, against $3.01M a year earlier. Over the last 5 years it ranged from -$137.29M to $546.86M, with a median of -$17.92M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 9, 2026 | -$64.19M | -453.7% |
| 2025 | Dec 31, 2025 | $18.15M | – |
| 2024 | Dec 31, 2024 | -$48.76M | – |
| 2023 | Dec 29, 2023 | -$108.68M | -185.5% |
| 2022 | Dec 30, 2022 | $127.11M | -54.8% |
| 2021 | Dec 31, 2021 | $281.27M | -67.9% |
| 2020 | Dec 31, 2020 | $875.17M | -6.4% |
| 2019 | Dec 31, 2019 | $934.53M | +158.4% |
| 2018 | Dec 31, 2018 | $361.66M | +8.5% |
| 2017 | Dec 29, 2017 | $333.27M | +35.2% |
| 2016 | Dec 30, 2016 | $246.59M | -11.3% |
| 2015 | Dec 31, 2015 | $277.95M | -72.0% |
| 2014 | Dec 31, 2014 | $993.63M | +15268.1% |
| 2013 | Dec 31, 2013 | $6.47M | – |
See a number that looks wrong?